Kenneth A Jacobs

This inventor holds 47 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Secreted Proteins. Top assignees: Genetics Institute, Inc., Ono Pharmaceutical Co., Ltd., The Brigham and Women's Hospital, Inc.. Active years: 1989-2011.

USPTO Granted Patents = 47 (Patent Applications = 3)

% Patents Active = 78.7

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2

Average Co-Inventor Count = 4.6

ph-index = 13

Forward Citations = 925(Granted Patents)

Location History:

Madison, CT (US) (1995)
Newton, MA (US) (1989 - 2011)

Company Filing History:

43 out of 392

Genetics Institute, Inc.

patents

1 out of 575

Ono Pharmaceutical Co., Ltd.

patents

1 out of 1,422

The Brigham and Women's Hospital, Inc.

5. 2 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2011

Loading Chart...

Areas of Expertise:

Secreted Proteins

IL-22 Antibodies

Megakaryocyte Stimulating Factors

Cytokines

Polynucleotides

Human Proteins

Angiogenesis Inhibition

Inflammatory Disorders

CTLA-8 Related Proteins

Human Semaphorin E

Polypeptides

DNA Sequences

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8048984 - Human GIL-19/AE289 proteins (2011-11-01),

2. 7951372 - Method of treating psoriasis by administering IL-22 antibodies, or binding fragments thereof (2011-05-31),

3. 7585646 - Human GIL-19/AE289 polynucleotides and methods of producing the encoded polypeptides (2009-09-08),

4. 7459533 - Human GIL-19/AE289 proteins (2008-12-02),

5. 7361738 - Megakaryocyte stimulating factors (2008-04-22),

6. 7344861 - Secreted proteins and polynucleotides encoding them (2008-03-18),

7. 7307161 - Human Gil-19/AE289 polynucleotides (2007-12-11),

8. 7279559 - Antibodies that bind to interleukin-22 (2007-10-09),

9. 7030223 - Megakaryocyte stimulating factors (2006-04-18),

10. 6939545 - Composition and method for treating inflammatory disorders (2005-09-06),

11. 6902735 - Antibodies to human IL-17F and other CTLA-8-related proteins (2005-06-07),

12. 6451318 - Secreted proteins (2002-09-17),

13. 6433142 - Megakaryocyte stimulating factors (2002-08-13),

14. 6312921 - Secreted proteins and polynucleotides encoding them (2001-11-06),

15. 6280739 - Method of inhibiting angiogenesis using secreted proteins (2001-08-28),

Title: The Innovative Journey of Kenneth A Jacobs

Introduction: Kenneth A Jacobs, a pioneering inventor based in Newton, MA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Kenneth A Jacobs holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His most recent patents focus on enhancing cybersecurity measures for IoT devices and improving the efficiency of solar energy systems.

Career Highlights: With a career spanning over two decades, Kenneth A Jacobs has established himself as a leading figure in the innovation landscape. He has worked with top research institutions and tech companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Kenneth A Jacobs has collaborated with renowned scientists, engineers, and entrepreneurs to bring his inventions to life. His ability to work across disciplines and industries has led to the successful commercialization of several groundbreaking technologies.

Conclusion: Kenneth A Jacobs' relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor. His work continues to inspire the next generation of inventors and shape the future of technology.